Skip to main content

In-vitro diagnostics

06
Mar 2024

New version of NABM nomenclature released

On February 15, 2024, the new version of the Nomenclature of Medical Biology Acts was released in France. Various changes were implemented, including the introduction of five new codes and modification of the existing codes and titles. The newly introduced codes concern microbiological and biochemical tests.
06
Feb 2024

Eight NHS Genomic Networks of Excellence launched in England

In January 2024, eight NHS Genomic Networks of Excellence were launched within the NHS Genomic Medicine Service (GMS). NHS England is funding these innovative networks to develop the evidence and model of adoption for cutting-edge genomic advances and technology applications and inform commissioning decisions.
01
Feb 2024

2024/25 National Genomic Test Directory released in England

In January 2024, NHS England issued an updated version of the National Genomic Test Directory for 2024/2025, which lists genomic tests commissioned by NHS England via Genomic Laboratory Hubs. Six new codes (test-indication combinations) were introduced in the Test Directory for cancer, and four new codes in the Test Directory for rare and inherited diseases.
22
Dec 2023

The revised EBM catalog for the first quarter of 2024 published in Germany

On December 21, 2023, the revised EBM (German Uniform Evaluation Standard) catalog for the first quarter of 2024 was published. The most significant changes concern the update of Annex 2 of the catalog, the introduction of the new EBM codes for external electrical cardioversion in adult and pediatric patients, follow-up and evaluation of the health app companion patella, as well as a companion diagnostics test for genotyping to determine CYP2C19 metabolism status.
21
Dec 2023

Updates in the coverage of medical services in Switzerland in 2024

On November 29, 2023, the Swiss Federal Office of Public Health published the changes that will occur to the Services Ordinance (KLV/OPre), which determines coverage of medical services in Switzerland. The updates will enter into force on January 1 or July 1, 2024, and they relate to the list of explicitly evaluated services (Annex 1 of KLV/OPre), outpatient-before-hospital services (Annex 1a), List of Tools and Equipment (Annex 2), and List of Analyses (Annex 3).
11
Dec 2023

The 2024 version of the SwissDRG released

On November 30, 2023, the entity managing the DRG system in Switzerland, SwissDRG, published the final version of the 2024 DRG system. In total, 34 new DRGs were introduced, and they concern cardiovascular, endocrine, gastrointestinal, men’s health, nephrology and urology, neurology and neurosurgery, neuromodulation, obstetrics and gynecology, orthopedics, pulmonary, and some other technology groups. Also, two new add-on reimbursement categories were introduced.
27
Nov 2023

Reduction of reimbursement for the clinical laboratory by 15% in Belgium

In November 2023, the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) announced the budget reduction for reimbursement of clinical laboratory services by 15% from January 2024. INAMI-RIZIV considers this reimbursement still sufficient and will reallocate released funds to other projects in health care. The reduction will not impact molecular biological and genetic testing.
25
Oct 2023

Ongoing HTAs by OSTEBA in Spain in late October 2023

In late October 2023, the Basque Office for Health Technology Assessment (OSTEBA) is working on several HTAs, including the evaluations in the cardiovascular, diagnostic imaging, e-health, ENT, ICU/OR, nephrology and urology, IVD, neurovascular, obstetrics and gynecology, surgical procedures, and some other fields.
12
Oct 2023

The revised EBM catalog came into force in Germany in October 2023

The revised EBM (German Uniform Evaluation Standard) catalog came into force on October 1, 2023. The most significant changes concern the introduction of the new EBM codes for several IVD tests, prostate-specific membrane antigen (PSMA) positron emission tomography, as well as for stereotactic radiosurgery (SRS) in vestibular schwannomas.
21
Sep 2023

Ongoing HTAs by IACS in Spain in September 2023

In September 2023, the Health Sciences Institute in Aragon (IACS) is working on several HTAs, including evaluations in diagnostic imaging, endocrine, IVD, neuromodulation, orthopedics, peripheral vascular, and some other fields.